The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Site maintenance Monday, July 8th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip main navigation
Close Drawer MenuOpen Drawer Menu

Advancing Neuropsychiatric Practice, Training, and Research for 30 Years: ANPA’s Committee on Research


October 2023

Advancing Neuropsychiatric Practice, Training, and Research for 30 Years: ANPA’s Committee on Research

The American Neuropsychiatric Association Committee on Research (ANPA CoR), founded in 1993, seeks to advance medical knowledge and clinical practice in the transdisciplinary area that is neuropsychiatry. The committee members are clinician-scientists in behavioral neurology & neuropsychiatry, neuropsychology, and other disciplines in the clinical neurosciences based in North America, Central and South America, and Europe. Through the Journal of Neuropsychiatry and Clinical Neurosciences, the ANPA CoR publishes scholarly works on issues of scientific and clinical importance to our field, including systematic reviews and meta-analyses, scholarly narrative reviews, position papers, expert consensus guidance documents, and clinical practice recommendations.

This Editor’s Choice collection showcases the contributions of the ANPA CoR to the scientific literature since inception of its work. The articles in this collection align fully with ANPA’s mission “to improve the lives of persons with disorders and the interface of psychiatry and neurology” and its vision “to transform recognition, understanding, and treatment of neuropsychiatric disorders.” The articles in this collection, presented in reverse chronological order, have been cited over 2,000 times, with an average of more than 80 citations per article.

Selma Aybek, M.D., Mandana Modirrousta, M.D., Ph.D., David B. Arciniegas, M.D.

Advancing Neuropsychiatric Practice, Training, and Research for 30 Years: ANPA’s Committee on Research

Neuropsychiatry’s Role in the Postacute Sequelae of COVID-19: Report From the American Neuropsychiatric Association Committee on Research
Gaston Baslet, M.D., Selma Aybek, M.D., Simon Ducharme, M.D., M.Sc., Mandana Modirrousta, M.D., Ph.D., Timothy R. Nicholson, M.D., Ph.D.
2022, Volume 34, Issue 4, pp 341–350

Distinguishing Behavioral Variant Frontotemporal Dementia From Primary Psychiatric Disorders: A Review of Recently Published Consensus Recommendations From the Neuropsychiatric International Consortium for Frontotemporal Dementia
Peter S. Pressman, M.D., Daniel Matlock, M.D., Simon Ducharme, M.D.
2021, Volume 33, Issue 2, pp 152–156

Evidence-Based Practice for the Clinical Assessment of Psychogenic Nonepileptic Seizures: A Report From the American Neuropsychiatric Association Committee on Research
Gaston Baslet, M.D., Sepideh N. Bajestan, M.D., Ph.D., Selma Aybek, M.D., Mandana Modirrousta, M.D., Ph.D., Jason Price, D.Clin.Psy., Andrea Cavanna, M.D., Ph.D., David L. Perez, M.D., Shelby Scott Lazarow, Psy.D., Geoffrey Raynor, M.D., Valerie Voon, M.D., Ph.D., Simon Ducharme, M.D., M.Sc., W. Curt LaFrance Jr., M.D., M.P.H.
2021, Volume 33, Issue 1, pp 27–42

A Review and Expert Opinion on the Neuropsychiatric Assessment of Motor Functional Neurological Disorders
David L. Perez, M.D., M.M.Sc., Selma Aybek, M.D., Stoyan Popkirov, M.D., Kasia Kozlowska, M.B.B.S., Ph.D., Christopher D. Stephen, M.B.Ch.B., M.R.C.P., Jordan Anderson, D.O., Robert Shura, Psy.D., A.B.P.P., Simon Ducharme, M.D., M.Sc., Alan Carson, M.D., Ph.D., Mark Hallett, M.D., Timothy R. Nicholson, M.D., Ph.D., Jon Stone, Ph.D., F.R.C.P., W. Curt LaFrance Jr., M.D., M.P.H., Valerie Voon, M.D., Ph.D. (On behalf of the American Neuropsychiatric Association Committee for Research)
2021, Volume 33, Issue 1, pp 14–26

Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Review of Psychiatric Phenotypes and Management Considerations: A Report of the American Neuropsychiatric Association Committee on Research
Rani A. Sarkis, M.D., M.Sc., M. Justin Coffey, M.D., Joseph J. Cooper, M.D., Islam Hassan, F.R.A.N.Z.C.P., F.R.C.P.C., Belinda Lennox, D.M., F.R.C.Psych.
2019, Volume 31, Issue 2, pp 137–142

Noncognitive Behavioral Changes Associated With Alzheimer’s Disease: Implications of Neuroimaging Findings
Jeff Victoroff, M.D., Feng V. Lin, Ph.D., Kerry L. Coburn, Ph.D., Samuel D. Shillcutt, Pharm.D., Ph.D., Valerie Voon, M.D., Ph.D., Simon Ducharme, M.D., M.Sc.
2018, Volume 30, Issue 1, pp 14–21

Psychiatric Presentations of C9orf72 Mutation: What Are the Diagnostic Implications for Clinicians?
Simon Ducharme, M.D., M.Sc., F.R.C.P.(C), Sepideh Bajestan, M.D., Ph.D., Bradford C. Dickerson, M.D., Valerie Voon, M.D., Ph.D.
2017, Volume 29, Issue 3, pp 195–205

Neurobiology of the Premonitory Urge in Tourette’s Syndrome: Pathophysiology and Treatment Implications
Andrea E. Cavanna, M.D., Ph.D., F.R.C.P., Kevin J. Black, M.D., Mark Hallett, M.D., Valerie Voon, M.D., Ph.D.
2017, Volume 29, Issue 2, pp 95–104

Functional Neuroanatomy and Neurophysiology of Functional Neurological Disorders (Conversion Disorder)
Valerie Voon, M.D., Ph.D., Andrea E. Cavanna, M.D., Ph.D., Kerry Coburn, Ph.D., Shirlene Sampson, M.D., Alya Reeve, M.D., W. Curt LaFrance Jr., M.D. (On behalf of the American Neuropsychiatric Association Committee for Research)
2016, Volume 28, Issue 3, pp 168–190

Pharmacological Management of Persistent Hostility and Aggression in Persons With Schizophrenia Spectrum Disorders: A Systematic Review
Jeff Victoroff, M.D., Kerry Coburn, M.A., Ph.D., Alya Reeve, M.D., Shirlene Sampson, M.D., Samuel Shillcutt, Ph.D., Pharm.D.
2014, Volume 26, Issue 4, pp 283–312

Psychopharmacological Neuroprotection in Neurodegenerative Diseases, Part III: Criteria-Based Assessment: A Report of the ANPA Committee on Research
Edward C. Lauterbach, M.D., Mario F. Mendez, M.D., Ph.D.
2011, Volume 23, Issue 3, pp 242–260

Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications
Edward C. Lauterbach, M.D., Samuel D. Shillcutt, Pharm.D., Ph.D, Jeff Victoroff, M.D., Kerry L. Coburn, Ph.D., Mario F. Mendez, M.D., Ph.D.
2010, Volume 22, Issue 2, pp 130–154

Psychopharmacological Neuroprotection in Neurodegenerative Disease: Assessing the Preclinical Data
Edward C. Lauterbach, M.D., Jeff Victoroff, M.D., Kerry L. Coburn, Ph.D., Samuel D. Shillcutt, Pharm.D., Ph.D., Suzanne M. Doonan, M.S., Mario F. Mendez, M.D., Ph.D.
2010, Volume 22, Issue 1, pp 8–18

Neuroanatomy of Pathological Laughing and Crying: A Report of the American Neuropsychiatric Association Committee on Research
Josef Parvizi, M.D., Ph.D., Kerry L. Coburn, Ph.D., Samuel D. Shillcutt, Ph.D., C. Edward Coffey, M.D., Edward C. Lauterbach, M.D., Mario F. Mendez, M.D., Ph.D.
2009, Volume 21, Issue 1, pp 75–87

An Evidence-Based Review of the Psychopathology of Frontotemporal Dementia: A Report of the ANPA Committee on Research
Mario F. Mendez, M.D., Ph.D., Edward C. Lauterbach, M.D., Shirlene M. Sampson, M.D., ANPA Committee on Research
2008, Volume 20, Issue 2, pp 130–149

The Cognitive Correlates of Functional Status: A Review From the Committee on Research of the American Neuropsychiatric Association
Donald R. Royall, M.D., Edward C. Lauterbach, M.D., Daniel Kaufer, M.D., Paul Malloy, Ph.D., Kerry L. Coburn, Ph.D., Kevin J. Black, M.D.
2007, Volume 19, Issue 3, pp 249–265

Neuropsychiatric Complications of Traumatic Brain Injury: A Critical Review of the Literature (A Report by the ANPA Committee on Research)
Edward Kim, M.D., Edward C. Lauterbach, M.D., Alya Reeve, M.D., David B. Arciniegas, M.D., Kerry L. Coburn, Ph.D., Mario F. Mendez, M.D., Ph.D., Teresa A. Rummans, M.D., Edward C. Coffey, M.D.
2007, Volume 19, Issue 2, pp 106–127

The Value of Quantitative Electroencephalography in Clinical Psychiatry: A Report by the Committee on Research of the American Neuropsychiatric Association
Kerry L. Coburn, Ph.D., Edward C. Lauterbach, M.D., Nash N. Boutros, M.D., Kevin J. Black, M.D., David B. Arciniegas, M.D., C. Edward Coffey, M.D.
2006, Volume 18, Issue 4, pp 460–500

Executive Control Function: A Review of Its Promise and Challenges for Clinical Research: A Report From the Committee on Research of the American Neuropsychiatric Association
Donald R. Royall, M.D., Edward C. Lauterbach, M.D., Jeffrey L. Cummings, M.D., Allison Reeve, M.D., Teresa A. Rummans, M.D., Daniel I. Kaufer, M.D., W. Curt LaFrance, Jr., M.D., C. Edward Coffey, M.D.
2002, Volume 14, Issue 4, pp 377–405

The Use of Herbal Alternative Medicines in Neuropsychiatry: A Report of the ANPA Committee on Research
W. Curt LaFrance Jr., M.D., Edward C. Lauterbach, M.D., C. Edward Coffey, M.D., Stephen P. Salloway, M.D., M.S., Daniel I. Kaufer, M.D., Alison Reeve, M.D., Donald R. Royall, M.D., Elizabeth Aylward, Ph.D., Teresa A. Rummans, M.D., Mark R. Lovell, Ph.D.
2000, Volume 12, Issue 2, pp 177–192

Pharmacologic Efficacy in Neuropsychiatry: A Review of Placebo-Controlled Treatment Trials: A Report of the ANPA Committee on Research
Teresa A. Rummans, M.D., Edward C. Lauterbach, M.D., C. Edward Coffey, M.D., Donald R. Royall, M.D., Jeffrey L. Cummings, M.D., Stephen Salloway, M.D., James Duffy, M.D., Daniel Kaufer, M.D.
1999, Volume 11, Issue 2, pp 176–189

Neuropsychiatric Correlates and Treatment of Lenticulostriatal Diseases: A Review of the Literature and Overview of Research Opportunities in Huntington’s, Wilson’s, and Fahr’s Diseases: A Report of the ANPA Committee on Research
Edward C. Lauterbach, M.D., Jeffrey L. Cummings, M.D., James Duffy, M.B., Ch.B., C. Edward Coffey, M.D., Daniel Kaufer, M.D., Mark Lovell, Ph.D., Paul Malloy, Ph.D., Alison Reeve, M.D., Donald R. Royall, M.D., Teresa A. Rummans, M.D., Stephen P. Salloway, M.D.
1998, Volume 10, Issue 3, pp 249–266

The Clinician-Scientist in Neuropsychiatry: A Position Statement From the Committee on Research of the American Neuropsychiatric Association
Jeffrey L. Cummings, M.D., C. Edward Coffey, M.D., James D. Duffy, M.D., Edward C. Lauterbach, M.D., Mark Lovell, Ph.D., Paul F. Malloy, Ph.D., Donald R. Royall, M.D., Teresa A. Rummans, M.D., Stephen Salloway, M.D., M.S.
1998, Volume 10, Issue 1, pp 1–9

Cognitive Screening Instruments in Neuropsychiatry: A Report of the Committee on Research of the American Neuropsychiatric Association
Paul F. Malloy, Ph.D., Jeffrey L. Cummings, M.D., C. Edward Coffey, M.D., James Duffy, M.B., Ch.B., Max Fink, M.D., Edward C. Lauterbach, M.D., Mark Lovell, Ph.D., Donald Royall, M.D., Stephen Salloway, M.D.
1997, Volume 9, Issue 2, pp 189–197

Assessment of Treatment Outcomes in Neuropsychiatry: A Report From the Committee on Research of the American Neuropsychiatric Association
C. Edward Coffey, M.D., Jeffrey L. Cummings, M.D., James D. Duffy, M.B., Ch.B., Max Fink, M.D., Edward C. Lauterbach, M.D., Mark R. Lovell, Ph.D., Paul Malloy, Ph.D., Paul D. Nussbaum, Ph.D., Donald R. Royall, M.D., Stephen Salloway, M.D.
1995, Volume 7, Issue 3, pp 287–289

Browse all Editor’s Choice collections